Zentalis Pharmaceuticals Shares Rise After Leerink Upgrade
MT newswire2026/10/05 19:3203:32 PM EDT, 10/05/2026 (MT Newswires) -- Zentalis Pharmaceuticals (ZNTL) shares rose nearly 11% in Monday afternoon trading after Leerink upgraded the stock to outperform from market perform. Trading volume stood at 2.6 million shares, compared with a daily average of 1.2 million. Price: 2.80, Change: +0.28, Percent Change: +11.11
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Amid opposition to data centers, Musk doubles down: SpaceX (SPCX.US) plans to build a $24 billion computing center and gas power plant in Texas.
According to a public hearing notice published on the Starbase website, SpaceX plans to build, own, and operate a gas-fired power plant and a supercomputing facility at its company town in Starbase, Texas.
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts